Oppenheimer & CO Inc Clearside Biomedical, Inc. Transaction History
Oppenheimer & CO Inc
- $6.52 Billion
- Q4 2024
A detailed history of Oppenheimer & CO Inc transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 14,341 shares of CLSD stock, worth $16,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,341Holding current value
$16,205% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLSD
# of Institutions
55Shares Held
12.1MCall Options Held
54.7KPut Options Held
50.7K-
Vanguard Group Inc Valley Forge, PA2.84MShares$3.21 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$2.48 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.93MShares$2.18 Million0.04% of portfolio
-
Black Rock Inc. New York, NY798KShares$901,8940.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny745KShares$841,7240.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $68M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...